Geode Capital Management
APYX icon

Geode Capital Management’s Apyx Medical APYX Stock Holding History

Geode Capital Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.45M Buy
391,356
+32,527
+9% +$122K ﹤0.01% 3240
2025
Q4 		$1.26M Buy
358,829
+7,551
+2% +$26.3K ﹤0.01% 3311
2025
Q3 		$752K Buy
351,278
+1,644
+0.5% +$3.48K ﹤0.01% 3485
2025
Q2 		$787K Sell
349,634
-8,517
-2% -$12K ﹤0.01% 3408
2025
Q1 		$491K Buy
358,151
+5,342
+2% +$7.36K ﹤0.01% 3551
2024
Q4 		$558K Buy
352,809
+24,596
+7% +$34.4K ﹤0.01% 3565
2024
Q3 		$407K Buy
328,213
+1,768
+0.5% +$2.23K ﹤0.01% 3672
2024
Q2 		$438K Buy
326,445
+10,576
+3% +$15.6K ﹤0.01% 3612
2024
Q1 		$430K Buy
315,869
+6,052
+2% +$12.9K ﹤0.01% 3669
2023
Q4 		$812K Buy
309,817
+8,299
+3% +$20.1K ﹤0.01% 3433
2023
Q3 		$965K Sell
301,518
-10,723
-3% -$50K ﹤0.01% 3337
2023
Q2 		$1.57M Buy
312,241
+23,552
+8% +$119K ﹤0.01% 3189
2023
Q1 		$831K Hold
288,689
– – ﹤0.01% 3428
2022
Q4 		$675K Buy
288,689
+2,535
+0.9% +$7.74K ﹤0.01% 3539
2022
Q3 		$1.28M Buy
286,154
+498
+0.2% +$3.57K ﹤0.01% 3267
2022
Q2 		$1.67M Sell
285,656
-223,259
-44% -$1.15M ﹤0.01% 3182
2022
Q1 		$3.32M Buy
508,915
+11,151
+2% +$110K ﹤0.01% 3009
2021
Q4 		$6.38M Buy
497,764
+2,294
+0.5% +$32.1K ﹤0.01% 2749
2021
Q3 		$6.86M Buy
495,470
+5,388
+1% +$56.7K ﹤0.01% 2723
2021
Q2 		$5.05M Buy
490,082
+115
+0% +$1.14K ﹤0.01% 2905
2021
Q1 		$4.73M Buy
489,967
+36,788
+8% +$368K ﹤0.01% 2815
2020
Q4 		$3.26M Buy
453,179
+10,343
+2% +$68.5K ﹤0.01% 2829
2020
Q3 		$2.08M Buy
442,836
+4,589
+1% +$22.7K ﹤0.01% 2858
2020
Q2 		$2.43M Buy
438,247
+22,734
+5% +$94.5K ﹤0.01% 2735
2020
Q1 		$1.49M Buy
415,513
+19,843
+5% +$133K ﹤0.01% 2827
2019
Q4 		$3.35M Buy
395,670
+12,580
+3% +$90.9K ﹤0.01% 2699
2019
Q3 		$2.59M Buy
383,090
+5,263
+1% +$37.3K ﹤0.01% 2786
2019
Q2 		$2.54M Buy
377,827
+164,187
+77% +$893K ﹤0.01% 2788
2019
Q1 		$1.35M Buy
+213,640
New +$1.65M ﹤0.01% 3042
2018
Q4 		– Sell
-175,940
Closed -$1.25M – 4147
2018
Q3 		$1.25M Buy
175,940
+72,212
+70% +$401K ﹤0.01% 3121
2018
Q2 		$451K Hold
103,728
– – ﹤0.01% 3475
2018
Q1 		$308K Hold
103,728
– – ﹤0.01% 3558
2017
Q4 		$269K Hold
103,728
– – ﹤0.01% 3577
2017
Q3 		$350K Hold
103,728
– – ﹤0.01% 3477
2017
Q2 		$256K Hold
103,728
– – ﹤0.01% 3593
2017
Q1 		$276K Hold
103,728
– – ﹤0.01% 3536
2016
Q4 		$372K Buy
103,728
+30,146
+41% +$134K ﹤0.01% 3382
2016
Q3 		$383K Hold
73,582
– – ﹤0.01% 3354
2016
Q2 		$120K Hold
73,582
– – ﹤0.01% 3750
2016
Q1 		$122 Hold
73,582
– – ﹤0.01% 3780
2015
Q4 		$154K Hold
73,582
– – ﹤0.01% 3768
2015
Q3 		$145K Hold
73,582
– – ﹤0.01% 3784
2015
Q2 		$205K Hold
73,582
– – ﹤0.01% 3581
2015
Q1 		$175K Buy
73,582
+34,954
+90% +$116K ﹤0.01% 3623
2014
Q4 		$140K Buy
38,628
+8,987
+30% +$34.9K ﹤0.01% 3707
2014
Q3 		$118K Hold
29,641
– – ﹤0.01% 3719
2014
Q2 		$107K Buy
29,641
+1,661
+6% +$6.71K ﹤0.01% 3681
2014
Q1 		$107K Hold
27,980
– – ﹤0.01% 3646
2013
Q4 		$59K Hold
27,980
– – ﹤0.01% 3674
2013
Q3 		$79K Hold
27,980
– – ﹤0.01% 3527
2013
Q2 		$83K Buy
+27,980
New +$94.1K ﹤0.01% 3450

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Geode Capital Management's APYX Position: Q1 2026 in Review

Geode Capital Management increased its Apyx Medical (APYX) stake by 9.1% in Q1 2026, buying an estimated $122K and bringing the position to 391,356 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #3240.

Geode Capital Management first reported a position in APYX in Q2 2013 and has held it in 51 quarters since. The position peaked at $6.86M in Q3 2021. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

  • Geode Capital Management held 391,356 shares of Apyx Medical worth $1.45M as of Q1 2026.
  • Geode Capital Management bought 32,527 Apyx Medical shares in Q1 2026, an estimated $122K.
  • Apyx Medical made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3240 holding.
  • Geode Capital Management first reported a position in Apyx Medical in Q2 2013 and has held it in 51 quarters since.
  • Geode Capital Management's Apyx Medical position peaked at $6.86M in Q3 2021.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.